微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 42.59% | -0.85% | 2.12% | 19/52 | 36.42% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-06-30 | 41.71% | 0.34% | 2.89% | 20/52 | 36.51% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 40.54% | -0.98% | -5.14% | 21/52 | 36.38% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.73% | -3.5% | -0.53% | 20/52 | 38.59% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 42.96% | -2.11% | 3.35% | 22/52 | 40.29% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 41.57% | -1.54% | 1.54% | 24/52 | 40.13% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 40.94% | -2.93% | -7.55% | 24/52 | 39.27% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 44.28% | 3.25% | 0.89% | 20/52 | 40.44% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 43.89% | 6.72% | 3.95% | 23/52 | 41.37% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 42.22% | 7.24% | 0.11% | 26/52 | 40.21% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 42.17% | 5.01% | -1.67% | 25/52 | 38.93% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 42.89% | 22.11% | 4.29% | 28/52 | 42.21% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 41.13% | 2% | 4.47% | 25/52 | 43.4% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 39.37% | 47.52% | -1.98% | 30/52 | 42.88% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 40.16% | 2% | 14.35% | 20/52 | 40.06% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 35.12% | -10.29% | 31.62% | 40/52 | 38.9% | 成都先导 | 79.36% | 行业排名> |
| 2020-06-30 | 26.69% | -28.87% | -31.84% | 33/52 | 39.73% | 成都先导 | 75.92% | 行业排名> |
| 2019-12-31 | 39.15% | -8.7% | 4.37% | 33/52 | 43.15% | 南华生物 | 78.74% | 行业排名> |
| 2019-06-30 | 37.52% | -4.75% | -12.52% | 23/52 | 45.53% | 成都先导 | 80.82% | 行业排名> |
| 2018-12-31 | 42.89% | 0.19% | 8.88% | 23/52 | 42.47% | 成都先导 | 81.55% | 行业排名> |
| 2018-06-30 | 39.39% | 2% | -7.98% | 24/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2017-12-31 | 42.81% | -10.82% | -10.82% | 17/52 | 41.42% | 海特生物 | 87.74% | 行业排名> |
| 2016-12-31 | 48% | 2% | 2% | 10/52 | 40.69% | 海特生物 | 88.04% | 行业排名> |